Antiplatelet and Anticoagulant Therapy After Intracerebral Hemorrhage
- 1 May 2015
- journal article
- review article
- Published by Elsevier in Neurologic Clinics
- Vol. 33 (2) , 329-345
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or RivaroxabanStroke, 2014
- Death and Disability from Warfarin-Associated Intracranial and Extracranial HemorrhagesThe American Journal of Medicine, 2007
- Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial FibrillationJACC, 2007
- Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial FibrillationAnnals of Internal Medicine, 2004
- Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation PatientsStroke, 2004
- Prediction of Functional Outcome and In-Hospital Mortality After Admission With Oral Anticoagulant–Related Intracerebral HemorrhageStroke, 2000
- What causes intracerebral hemorrhage during warfarin therapy?Neurology, 2000
- Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and HypothesisCerebrovascular Diseases, 1999
- Early Hemorrhage Growth in Patients With Intracerebral HemorrhageStroke, 1997
- Prognostic factors in patients with intracerebral haematoma.Journal of Neurology, Neurosurgery & Psychiatry, 1992